Scientists in Brazil, the world’s second-biggest consumer of cocaine, have announced the development of an innovative new treatment for addiction to the drug and its potent derivative, crack: a vaccine.
Dubbed “Calixcoca,” the test vaccine, which has shown promising results in trials on animals, triggers an immune response that blocks cocaine and crack from reaching the brain, which researchers hope will help users break the cycle of addiction.
But, addicts would no longer get high from the drug.
If the treatment gets regulatory approval, it would be the first time cocaine addiction is treated using a vaccine, said psychiatrist Frederico Garcia, coordinator of the team that developed the treatment at the Federal University of Minas Gerais.